Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.

about

Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.

Item

http://www.wikidata.org/entity/Q36091141

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Sophisticated tests for suscep ...... ded value for heart hospitals.

@ast

Sophisticated tests for suscep ...... ded value for heart hospitals.

@en

type

Item

label

Sophisticated tests for suscep ...... ded value for heart hospitals.

@ast

Sophisticated tests for suscep ...... ded value for heart hospitals.

@en

prefLabel

Sophisticated tests for suscep ...... ded value for heart hospitals.

@ast

Sophisticated tests for suscep ...... ded value for heart hospitals.

@en

P1476

Sophisticated tests for suscep ...... ded value for heart hospitals.

@en

P2093

H Robert Superko

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Atherosclerosis — An Inflammatory Disease

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Infection and atherosclerosis: emerging mechanistic paradigms.

Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

Dynamics of reverse cholesterol transport: protection against atherosclerosis.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

P304

135-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1541-9215.2003.02362.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15815133

http://www.w3.org/2001/XMLSchema#string